Welcome everyone to Beta Bionics Annual Meeting of Stockholders. I am Sean Saint, President and CEO, as well as a member of the Board of Directors of Beta Bionics. We will conduct the business portion of our meeting first and answer any questions at the end of the meeting. Though we may not be able to answer every question, we will do our best to provide a response to as many as possible. I would like to introduce the other members of the board present today. Adam Lezack, Chairman of our Board of Directors, has served as the director since December 2023. Sean Carney has served as one of our directors since February 2020. Sean Carney and Christy Jones have been appointed as proxies on behalf of the board of directors for this meeting.
I would also like to introduce Jud Quiggle and Bryn Geraghty of Ernst & Young, the company's independent registered public accounting firm, who are also in attendance virtually and available to respond to appropriate questions as needed. Finally, it is my pleasure to introduce Beta Bionics Corporate Secretary and Chief Financial Officer, Stephen Feider. Stephen will act as secretary of the meeting, and I will turn to him with any procedural issues that may arise.
Thanks, Sean. The company has appointed Broadridge Financial Solutions to act as inspector of election. Chris Woods from Broadridge is with us today and has taken the oath of inspector of election, and this oath will be filed with the minutes of this meeting. The board of directors previously fixed March 23rd, 2026 as the record date for determining stockholders entitled to vote at this meeting. An affidavit of Broadridge has been delivered attesting to the fact that a notice of an internet availability of the proxy materials was mailed on or about April 10th, 2026 to all stockholders as of the record date and will be incorporated into the minutes of this meeting. We are informed by the inspector of election that a quorum is present for purposes of transacting business. Now, I will present the matters to be voted upon.
Proposal 1 is the election of two Class 1 directors to hold office until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified. The nominees for Class 1 director are Sean Carney and Christy Jones. Proposal 2 is to ratify the appointment by the company's audit committee of the board of Ernst & Young as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
It is now 2:05 P.M. Pacific Time on May 21st, 2026. With a quorum present, I declare the meeting duly and lawfully convened. The meeting is now open and ready for business, and the polls are open. Any stockholder who hasn't yet voted or wishes to change their vote may do so by clicking on the voting button on the web portal and following the instructions there. Stockholders who have sent in proxies or voted via telephone or internet and do not want to change their vote do not need to take any further action. We will now review if there are any questions submitted about the proposals or addressed to the auditors before we close the polls. As a reminder, we will only review and answer questions at this time that pertain to the proposals. Seeing none, no questions on the web portal.
We will now have a short pause for voting. Now that everyone has had the opportunity to vote, I now declare the polls for the annual meeting of stockholders closed.
We have been informed by the inspector of election that the preliminary vote report shows that the nominees for election to the board have been duly elected and the appointment of Ernst & Young as the company's independent registered public accounting firm has been ratified. We'll be reporting the final vote results in a Form 8-K to be filed within four business days. With that, I'll turn the meeting back over to Sean.
Thanks, Stephen. There being no further business to come before the meeting, Beta Bionics Annual Meeting of Stockholders is now adjourned.